Television

AMC's newest miniseries is an ill-advised attempt at a reboot of the cult-hit '60s spy series: A man known as Six (Jim Caviezel) finds himself trapped in a strange desert village, dogged b y a mysterious watcher (Ian McKellen's elusive Two). Critic David Bianculli says that despite McKellen's captivating performance, the remake has none of the curious genius of the original.

Four decades after its premiere, Sesame Street is the same happy neighborhood it always was. TV critic David Bianculli takes a look at the newest episode -- which features special guest Michelle Obama -- and assesses the show's enduring legacy.

Twenty-two years after its debut on ABC, the iconic TV drama about yuppie family life is back — in DVD form. Critic David Bianculli reviews the first season of thirtysomething, and reflects on what made the show both infuriating and fascinating.

TV critic David Bianculli reviews last night's Emmy awards — and considers the future of broadcast television in light of what the results revealed.

For all the claims to the contrary, The Jay Leno Show is as close to a clone of The Tonight Show as it can get without being sued.

When last we saw the ad men and women of AMC's Mad Men, the firm had just been bought by a British company and the Cuban missile crisis was underway. Critic David Bianculli offers a sneak peak at what additional drama the new season might hold.

Playing Shakespeare, a 1984 series in which actors dissect some of the Bard's most famous works, shows how crucial an understanding of Shakespeare's language and versification are to conveying the meaning — and power — of his scenes.

After 16 years as the host of the Late Night show, Conan O'Brien moves his act an hour earlier. TV critic David Bianculli reviews O'Brien's premiere as host of The Tonight Show.

Critic John Powers reviews the Starz comedy series Party Down, which follows a group of oddball dreamsers who work for a Hollywood catering company.

Tonight NBC devotes its entire prime-time schedule to a sendoff of ER, the medical drama series that has been running on the network since 1994. Critic David Bianculli wonders what comes next.